Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 1;44(12):e81-e83.
doi: 10.1097/IAE.0000000000004265.

Correspondence

Affiliations

Correspondence

Nicolas Feltgen et al. Retina. .
No abstract available

PubMed Disclaimer

References

    1. Boyer D, Hu A, Warrow D, et al. Lightsite III: 13-month efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative (dry) age-related macular degeneration using the LumiThera Valeda Light Delivery System. Retina 2024;44:487–497.
    1. Henein C, Steel DHW. Photobiomodulation for non-exudative age-related macular degeneration. Cochrane Database Syst Rev 2021;5:1–33.
    1. Markowitz SN, Devenyi RG, Munk MR, et al. A double-masked, randomized, sham-controlled, single-center study with photo-biomodulation for the treatment of dry age-related macular degeneration. Retina 2020;40:1471–1482.
    1. Burton B, Parodi MB, Jürgens I, et al. LIGHTSITE II Randomized Multicenter Trial: evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration. Ophthalmol Ther 2023;12:953–968.
    1. Grisanti S, Bartz-Schmidt U, Heimann H, et al. Letter to the editor regarding “LIGHTSITE II Randomized Multicenter Trial: evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration”. Ophthalmol Ther 2024;13:1051–1053.

LinkOut - more resources